A standard urinalysis does not test for drugs. It checks for things like sugar, protein, bacteria, and blood cells in your urine to evaluate kidney function, urinary tract infections, and other medical conditions. To detect drugs, a doctor or employer must specifically order a separate test called a urine drug screen or urine drug test. These are two completely different lab orders, even though both use a urine sample.
What a Standard Urinalysis Actually Tests
A routine urinalysis looks at three categories: the physical appearance of your urine (color, clarity), its chemical makeup, and what’s visible under a microscope. The chemical portion uses a dipstick to measure acidity (pH), protein, glucose, white blood cells, red blood cells, bilirubin, and a few other markers. These results help identify kidney disease, diabetes, liver problems, and infections. Nothing on that dipstick reacts to drug metabolites.
If your doctor orders a urinalysis as part of a routine physical or because you have symptoms like painful urination, that test will not reveal whether you’ve used marijuana, cocaine, or any other substance. The lab simply isn’t looking for those compounds.
How a Urine Drug Screen Works
A urine drug screen is a separate, purpose-built test that uses a method called immunoassay. Antibodies in the test react to specific drug byproducts in your urine. This is the type of test used in workplace screening, court-ordered monitoring, and clinical addiction treatment.
The most common version is the standard 5-panel test, originally established under the Drug-Free Workplace Act. It screens for five drug classes: marijuana (THC), cocaine, opiates (including heroin, morphine, and codeine), amphetamines and methamphetamines, and PCP. The Department of Transportation requires this exact panel for truck drivers and other regulated workers.
Many commercial and clinical settings now use expanded panels that go beyond those five. A 10-panel or 12-panel test typically adds benzodiazepines, barbiturates, methadone, and sometimes additional opioids like oxycodone and hydrocodone. This matters because the standard 5-panel test will miss several commonly prescribed medications and widely used substances, including alcohol, synthetic opioids like fentanyl, and synthetic cannabinoids.
What About Alcohol?
Neither a standard urinalysis nor a typical drug panel will detect alcohol use. Alcohol itself clears from urine within about 10 to 12 hours. To catch alcohol use over a longer window, a provider must order a specific test for a metabolite called ethyl glucuronide (EtG), which can be detected for up to 48 hours after drinking. This is always a separate order.
Detection Windows for Common Substances
Even on a proper drug screen, timing matters. Each substance leaves detectable traces in urine for a different length of time. Here are the general windows based on data from ARUP Laboratories:
- Marijuana (THC): 3 to 13 days with frequent use, and up to 45 days in heavy, long-term users
- Cocaine: 1 to 2 days
- Common opioids: codeine, morphine, hydrocodone, and oxycodone typically show for 1 to 3 days; fentanyl can be detected for 1 to 7 days; methadone for 1 to 14 days
- Benzodiazepines: 1 to 12 days depending on the specific drug (shorter-acting ones clear faster)
- Amphetamines: generally 1 to 3 days
These ranges vary with body weight, metabolism, hydration, frequency of use, and the specific cutoff levels the lab applies. Federal guidelines set the initial screening threshold for THC at 50 nanograms per milliliter, cocaine at 300, opiates at 300, amphetamines at 1,000, and PCP at 25. Anything below those concentrations registers as negative on the initial screen, even if trace amounts are technically present.
False Positives and Confirmation Testing
Initial immunoassay screens are fast but not perfectly precise. Certain medications can trigger false positives because their chemical structure is similar enough to a target drug to react with the test’s antibodies. Quinolone antibiotics, the blood pressure medication verapamil, the antihistamine diphenhydramine (Benadryl), and the sleep aid doxylamine have all been documented to cause false positives for opiates or methadone. Even poppy seeds can cause a true positive for opiates at sensitive cutoff levels.
This is why any positive result on an initial screen should be followed by confirmatory testing. The gold standard is a lab technique called mass spectrometry, which separates every compound in the sample by its molecular structure. Unlike immunoassay, this method can identify the exact substance and its metabolites, distinguishing between heroin and prescription morphine, for example, or between a legitimate medication and an illicit drug. Confirmatory testing takes longer and costs more, but it eliminates the ambiguity of a screening result.
If you dispute a positive result on a preliminary screen, guidelines from the American Society of Addiction Medicine recommend that a definitive confirmatory test be performed. If you acknowledge use of the detected substance, confirmation is generally unnecessary.
Why the Distinction Matters
The confusion between a urinalysis and a drug test is common, and it has real consequences. People sometimes assume a routine doctor’s visit will reveal drug use, or conversely, that a clean urinalysis means they “passed” a drug screen. These are different tests with entirely different purposes. A urinalysis evaluates your physical health. A drug screen evaluates the presence of specific substances. Your provider or employer must explicitly order whichever one they need, and in many cases both require your consent.
If you’re preparing for a workplace screening, the test ordered will almost certainly be labeled as a urine drug screen or toxicology panel, not a urinalysis. If you’re going in for a physical or a follow-up on urinary symptoms, the urinalysis your doctor orders will tell them about your kidneys and bladder, not about anything else in your system.